Search Results - "GILISSEN, Ron A"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs by DE BUCK, Stefan S, SINHA, Vikash K, FENU, Luca A, NIJSEN, Marjoleen J, MACKIE, Claire E, GILISSEN, Ron A. H. J

    Published in Drug metabolism and disposition (01-10-2007)
    “…The aim of this study was to evaluate different physiologically based modeling strategies for the prediction of human pharmacokinetics. Plasma profiles after…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Predicting Oral Clearance in Humans: How Close Can We Get with Allometry? by Sinha, Vikash K., De Buck, Stefan S., Fenu, Luca A., Smit, Johan W., Nijsen, Marjoleen, Gilissen, Ron A. H. J., Van Peer, Achiel, Lavrijsen, Karel, Mackie, Claire E.

    Published in Clinical pharmacokinetics (2008)
    “…Background Oral clearance (CL/F) is an important pharmacokinetic parameter and plays an important role in the selection of a safe and tolerable dose for…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Chiral capillary electrophoretic analysis of verapamil metabolism by cytochrome P450 3A4 by Ha, Pham Thi Thanh, Sluyts, Inge, Dyck, Sigrid Van, Zhang, Jie, Gilissen, Ron A.H.J., Hoogmartens, Jos, Schepdael, Ann Van

    Published in Journal of Chromatography A (07-07-2006)
    “…Cytochrome P450 (CYP), which is one of the most important enzymes in human liver, is responsible for a large portion of the first-pass metabolism of drugs…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Discovery of Potent, Orally Bioavailable Small-Molecule Inhibitors of the Human CCR2 Receptor by Doyon, Julien, Coesemans, Erwin, Boeckx, Staf, Buntinx, Mieke, Hermans, Bart, Van Wauwe, Jean P., Gilissen, RonA. H. J., De Groot, Alex H. J., Corens, David, Van Lommen, Guy

    Published in ChemMedChem (14-04-2008)
    “…We recently reported the discovery of a series of 2‐thioimidazoles as CCR2 antagonists. The most potent molecules of this series, the 4,5‐diesters, were…”
    Get full text
    Journal Article
  9. 9

    Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay by Fenu, Luca A., Teisman, Ard, De Buck, Stefan S., Sinha, Vikash K., Gilissen, Ron A. H. J., Nijsen, Marjoleen J. M. A., Mackie, Claire E., Sanderson, Wendy E.

    Published in Journal of computer-aided molecular design (01-12-2009)
    “…As chemists can easily produce large numbers of new potential drug candidates, there is growing demand for high capacity models that can help in driving the…”
    Get full text
    Journal Article
  10. 10

    Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients by de Witte, Wilhelmus E A, Wong, Yin Cheong, Nederpelt, Indira, Heitman, Laura H, Danhof, Meindert, van der Graaf, Piet H, Gilissen, Ron A H J, de Lange, Elizabeth C M

    Published in Expert opinion on drug discovery (02-01-2016)
    “…Drug-target binding kinetics are major determinants of the time course of drug action for several drugs, as clearly described for the irreversible binders…”
    Get more information
    Journal Article
  11. 11

    Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry by Kantharaj, E., Tuytelaars, An, Proost, Pascale E. A., Ongel, Zuleyha, van Assouw, Harrie P., Gilissen, Ron A. H. J.

    Published in Rapid communications in mass spectrometry (01-01-2003)
    “…The use of in vitro drug metabolism data in the understanding of in vivo pharmacokinetic, safety and toxicity data has become a large area of scientific…”
    Get full text
    Journal Article
  12. 12

    HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency by PAULUSSEN, Aimée D. C, RAES, Adam, JONGBLOED, Roselie J, GILISSEN, Ron A. H. J, WILDE, Arthur A. M, SNYDERS, Dirk J, SMEETS, Hubert J. M, AERSSENS, Jeroen

    Published in Cardiovascular research (15-08-2005)
    “…Mutations in the KCNH2 (hERG, human ether-à-go-go related gene) gene may cause a reduction of the delayed rectifier current I(Kr), thereby leading to the long…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    The use of liquid chromatography-atmospheric pressure chemical ionization mass spectrometry to explore the in vitro metabolism of cyanoalkyl piperidine derivatives by Kantharaj, E., Ehmer, Peter B., De Wagter, Katie, Tuytelaars, An, Proost, Pascale E. A., Mackie, Claire, Gilissen, Ron A. H. J.

    Published in Biomedical chromatography (01-04-2005)
    “…A LC/MS method using atmospheric pressure chemical ionization, positive ion mode and full scan to measure the in vitro metabolic stability of cyanoalkyl…”
    Get full text
    Journal Article
  16. 16

    Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations by COUGHTRIE, Michael W. H., GILISSEN, Ron A. H. J., SHEK, Benedicte, STRANGE, Richard C., FRYER, Anthony A., JONES, Peter W., BAMBER, Dianne E.

    Published in Biochemical journal (01-01-1999)
    “…Sulphation, catalysed by members of the sulphotransferase (SULT) enzyme family, is an important component of the body's chemical defence mechanism, but also…”
    Get full text
    Journal Article
  17. 17

    Phenol sulphotransferase SULT1A11 genotype is associated with reduced risk of colorectal cancer by BAMBER, Dianne E, FRYER, Anthony A, STRANGE, Richard C, ELDER, James B, DEAKIN, Mark, RAJAGOPAL, Ramesh, FAWOLE, Adeshina, GILISSEN, Ron A. H. J, CAMPBELL, F. Charles, COUGHTRIE, Michael W. H

    Published in Pharmacogenetics (London) (01-11-2001)
    “…Sulphation is an important detoxification pathway for numerous xenobiotics; however, it also plays an important role in the metabolism and bioactivation of…”
    Get full text
    Journal Article
  18. 18